Considering the anti-cancer findings, the metabolic reprogramming observed in alveolar macrophages (AMs) post-influenza infection, as depicted by elevated glycolysis, PI3K–Akt, HIF-1, and mTOR signalling, underscores the therapeutic promise of leveraging trained immunity against cancer. This evidence concerns the gene MTOR and influenza.